India  

Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR

Video Credit: HT Digital Content - Duration: 06:42s - Published
Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR

Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR

At present country has three Indian COVID-19 vaccines which are in different phases of clinical testing, said Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava on Tuesday.

Addressing a press conference in the national capital, he said, "At the present moment, we have three Indian vaccines which are in different phases of clinical testing.

The 2 vaccines- Bharat Biotech vaccine and DNA vaccine of Zydus Cadila have completed phase 1 and will begin phase 2 while third is Oxford vaccine." "Oxford vaccine, being manufactured by Serum Institute of India (SII) got approval for phase 2 and 3 clinical trials, which are starting within a week at 17 sites," he added.

Dr Bhargava, however, said that social distancing and proper hygiene are the best "vaccine" available now and even after.

"Physical Distancing, wearing a mask, proper hand hygiene are the best vaccine available at the moment and even after.

We will have to continue with these measures," he said.

India has so far recorded over 18 lakh cases and more than 38,900 deaths.


You Might Like

Related news from verified sources

Serum gets DCGI nod for Phase 2 & 3 trials

India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage...
IndiaTimes - Published


Related videos from verified sources

India's COVID tally crosses 36 lakh mark [Video]

India's COVID tally crosses 36 lakh mark

India crossed 36 lakh mark of coronavirus cases including 7,81,975 active cases on Aug 31. The spike of 78,512 new cases and 971 deaths reported in India in last 24 hours. With 971 deaths, cumulative..

Credit: ANI     Duration: 01:25Published
Bangladesh's Beximo signs covid-19 deal with India's Serum Institute, what is it: Watch | Oneindia [Video]

Bangladesh's Beximo signs covid-19 deal with India's Serum Institute, what is it: Watch | Oneindia

As the race for a COVID-19 vaccine rages on, Bangladesh's leading pharma company Beximco has announced it will be investing in Adar Poonawalla's Serum India Limited for development of the vaccine. The..

Credit: Oneindia     Duration: 01:08Published
India's COVID-19 cases cross 35 lakh mark [Video]

India's COVID-19 cases cross 35 lakh mark

India has recorded over 10 lakh COVID-19 tests in last 24 hours. The total number of samples have been tested up to August 26 is 4,14,61,636 including 10,55,027 samples tested yesterday. Meanwhile,..

Credit: ANI     Duration: 01:18Published